​

Purple Biotech Ownership | Who Owns Purple Biotech?


OverviewChart

Purple Biotech Ownership Summary


Purple Biotech is owned by 0.78% institutional investors, 3.73% insiders, and 95.49% retail investors. Sbi securities is the largest institutional shareholder, holding 1.29% of PPBT shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.04% of its assets in Purple Biotech shares.

PPBT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPurple Biotech0.78%3.73%95.49%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sbi securities31.001.29%$125.00
Smartharvest portfolios51.27K0.47%$77.93K
Hrt financial lp18.23K0.17%$27.00K
Jane street group14.00K0.13%$21.29K
Virtu financial19.27K0.07%$8.00K
Ubs group6.47K0.06%$9.84K
Geode capital management12.67K0.05%$5.26K
Citadel advisors5.60K0.02%$2.32K
Royal bank of canada2.16K0.01%$1.00K
Rhumbline advisers850.000.01%$1.29K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Smartharvest portfolios51.27K0.03%$77.93K
Virtu financial19.27K0.00%$8.00K
Sound income strategies---
Eversource wealth advisors---
Jane street group14.00K-$21.29K
North star investment management---
Rhumbline advisers850.00-$1.29K
Gamma investing---
Wealth advisors of iowa---
Td waterhouse canada---

Top Buyers

HolderShares% AssetsChange
Smartharvest portfolios51.27K0.03%22.80K
Jane street group14.00K-14.00K
Ubs group6.47K-5.72K
Hrt financial lp18.23K-3.59K
Virtu financial19.27K0.00%3.19K

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.36M
Kingswood wealth advisors---208.06K
Xtx topco---29.10K
Venture visionary partners---22.16K
Millennium management---21.44K

New Positions

HolderShares% AssetsChangeValue
Jane street group14.00K-14.00K$21.29K
Caitong asset management78.00-78.00$119.00
Sbi securities31.00-31.00$125.00

Sold Out

HolderChange
Danske bank-4.00
Jones financial companies lllp-5.00
Advisory services network-9.00
Tradewinds capital management-10.00
North star investment management-15.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202612-14.29%84,29711.42%-118.49%8300.00%3-75.00%
Mar 31, 20269-55.00%21,064-97.30%8770.01%1-90.00%860.00%
Dec 31, 20251-66.67%56-67.06%-15.93%--100.00%--
Sep 30, 20252-71129.03%-36720900.00%1---
Jun 30, 20252100.00%31106.67%--1---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index633.000.04%-

Insider Transactions Trends


DateBuySell
2026 Q1--

PPBT Ownership FAQ


Who Owns Purple Biotech?

Purple Biotech shareholders are primarily institutional investors at 0.78%, followed by 3.73% insiders and 95.49% retail investors. The average institutional ownership in Purple Biotech's industry, Biotech Stocks , is 385.89%, which Purple Biotech falls below.

Who owns the most shares of Purple Biotech?

Purple Biotech’s largest shareholders are Sbi securities (31 shares, 1.29%), Smartharvest portfolios (51.27K shares, 0.47%), and Hrt financial lp (18.23K shares, 0.17%). Together, they hold 1.93% of Purple Biotech’s total shares outstanding.

Does Blackrock own Purple Biotech?

BlackRock is not among the top 10 institutional shareholders of Purple Biotech.

Who is Purple Biotech’s biggest shareholder by percentage of total assets invested?

Smartharvest portfolios is Purple Biotech’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 51.27K Purple Biotech shares, valued at 77.93K$.

Who is the top mutual fund holder of Purple Biotech shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Purple Biotech shares, with 0.04% of its total shares outstanding invested in 633 Purple Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools